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Abstract
There are few reports about the treatment of moderate to severe hyponatremia associated with malignant
liver metastasis. Here, we report using intravenous salt poor albumin infusion to treat hypervolemic
cirrhosis related hyponatremia. A 58-year-old female with ascites secondary to metastatic breast cancer
was referred to our department with symptomatic hyponatremia (serum sodium concentration of 121
mEq/L). The serum sodium level was corrected slowly over 2 days with intravenous albumin infusion and
the patient's symptoms – fatigue, nausea, dizziness and headache improved.
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Introduction
Cirrhosis of the liver is frequently associated with chronic hypervolemic hyponatremia.[1] As prolonged
hyponatremia of even modest degree (125 mmol/l) may cause irreversible neurological damage,[2] it is
recommended that hyponatremia associated with cirrhosis should be treated once the serum sodium
decreased below 130 mEq/L. The cause of the hyponatremia in cirrhosis patients is related to a marked
reduction in systemic vascular resistance, especially in the splanchnic circulation and compensatory
activation of endogenous vasoconstrictors including the rennin-angiotensin system, the sympathetic
nervous system and antidiuretic hormone (ADH).[3] There are several reports showing that intravenous
albumin infusion could be used effectively to treat hyponatremia in cirrhotic patients with ascites.
[4,5,6,7,8,9] Massive hepatic metastasis also leads to ascites, few reports showed management of
hyponatremia under this condition. Here, we presented a case of a patient with massive hepatic metastasis
who presented to the hospital with a serum sodium concentration of 121 mEq/L, which corrected with
intravenous albumin infusion.
Case Report
A 58-year-old African American female was referred to renal service with hyponatremia and a 2-day
history of weakness, anorexia and headache. The patient had a medical history significant for metastatic
breast cancer and ascites requiring frequent therapeutic paracentesis. On physical exam, the patient was
noted to have marked ascites with a prominent fluid wave and bulging flanks, bilateral pitting edema
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below the knees. Her vitals were significant for a pulse of 78 beats/min, blood pressure of 102/68 mm/Hg.
Significant laboratory studies included a white blood cell count of 4.3 × 10 /L, aspartate transaminase of
111 U/L, alanine transaminase of 49 U/L, albumin of 2.4 g/dl, serum sodium concentration of 121 mEq/L,
and serum osmolality of 260 mosm/kg. Patient's serum sodium was 130-131 mEq/L at baseline. However,
in the past 3 days, she was given dextrose 5% in 0.45% normal saline (D5 ½ NS) infusion because of her
poor oral intake. Urine electrolytes showed urine sodium concentration of <10 mmol/L, and the urine
osmolality was 412 mos/kg. Computed tomography scan of the abdomen and pelvis showed innumerable
metastasis throughout the liver. A liver sonogram ruled out Budd Chiari's syndrome. The low urinary
sodium is consistent with low effective circulating volume depletion, in this case, secondary to large
amount of ascites and cirrhotic state. The urine osmolality of 412 mos/kg indicated an inability to normally
excrete free water, likely because of persistent secretion of ADH (SIADH). Therefore, a diagnosis of
hypervolemic hyponatremia in the setting of liver metastasis was made. SIADH was excluded based on the
volume status of the patient (not euvolemic).
The patient was treated with 100 ml 25% albumin intravenous infusion every 8 h for 2 days for her
symptomatic hyponatremia. She was on fluid restriction to <1200 cc/day and appropriately with sodium
restriction to less than 2300 mg/day. Her serum sodium concentration increased to 134 mEq/L over 48 h [
Figure 1] and her weakness, anorexia, and headache significantly improved. She was discharged from the
hospital with recommendations for fluid restriction. Her serum sodium concentration maintained in the
range of 134-140 mEq/L in the next 2 months after her discharge.
Discussion
Chronic hyponatremia (defined as a serum sodium concentration below 130 mEq/L) presents in up to 22%
of people with cirrhosis.[10] The prevalence of patients with cirrhosis and serum concentrations less than
or equal to 120 mEq/L is 1.2%.[11] Little data is available studying the prevalence of hyponatremia in
patients with liver metastasis. Acute worsening of chronic hyponatremia can be a result of one of the
following factors: Reduced effective arterial volume, generalized hemodynamic derangement with low
peripheral resistance, hypothalamic overproduction of ADH (not SIADH), diuretic use, hypotonic fluid
ingestion and reduced glomerular filtration.[10,12,13] In our patient, the intravenous infusion of D5 ½ NS
which contains hypotonic sodium chloride may be a factor for the acute worsening of the underlying
chronic hyponatremia.
Treatment of hyponatremia in patients with cirrhosis commonly includes sodium and fluid restriction,
treatment with spironolactone and loop diuretics. Infusion of 3% saline infusion and vasopressin receptor
antagonists have also been used to treat patients with profound hyponatremia and severe symptoms.
Increasing the intravascular volume using albumin has been shown to correct hyponatremia in patients
with cirrhosis by increasing urinary free water clearance.[4,5,6,7,8,9] In our patient, fluid restriction would
not be very effective since the patient already had diminished oral intake. We did not want to give the
patient diuretics as they can exacerbate the reduction in kidney perfusion, further impairing the ability to
excrete free water. By giving albumin infusion in this patient, we likely improved renal blood flow, and
improved free water clearance.
Albumin infusion may also have suppressed volume-mediated ADH by increasing the intravascular
volume. As noted before the patient's hypervolemic status excludes the possible diagnosis of SIADH and
the heightened ADH in cirrhotics is related to an appropriate response with reduced pulmonary vascular
response in splanchnic bed. We should mention that, while the serum sodium concentration in our patient
increased from 121 mEq/L to 134 mEq/L after albumin infusion, her serum albumin increased from 2.4
g/dl to 3.2 g/dl after 50 ml 25% albumin infusion ×6 times. The approximate sodium content in the 25%
albumin preparation is 145 mEq/L. The concentration of sodium itself in “salt poor” albumin 25% 50 cc
bag is close to 6.5-7.5 mEq only and 3 such infusions a day is not enough sodium intake to explain rise in
sodium observed in this patient. If we take into consideration of the Donnan effect of serum albumin on
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serum sodium (addition and reduction of 2 mmol/l for serum sodium per 1 g/dl decrease and increase of
serum albumin, respectively),[14] the actually change of serum sodium concentration should be 11.4
mEq/L (close to the change in our patient-13 mEq/L). In summary, we showed that intravenous of salt
poor albumin infusion is an effective therapy for hyponatremia in patients with liver metastasis, likely
using a mechanism similar to that in cirrhotic patients with ascites.
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Figure 1
Time course of changes in serum sodium in the patient
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